Your browser doesn't support javascript.
loading
Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies.
Lee, Namhee; Jeon, Yun-Hui; Yoo, Jiyoon; Shin, Suk-Kyung; Lee, Songyi; Park, Mi-Ju; Jung, Byung-Jin; Hong, Yun-Kyoung; Lee, Dong-Sup; Oh, Keunhee.
Afiliação
  • Lee N; Research Center, SillaJen, Inc, Seongnam, Gyeonggi-do, Republic of Korea.
  • Jeon YH; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Yoo J; Wide River Institute of Immunology, Seoul National University, Gangwon, Republic of Korea.
  • Shin SK; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lee S; Wide River Institute of Immunology, Seoul National University, Gangwon, Republic of Korea.
  • Park MJ; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Jung BJ; Wide River Institute of Immunology, Seoul National University, Gangwon, Republic of Korea.
  • Hong YK; Research Center, SillaJen, Inc, Seongnam, Gyeonggi-do, Republic of Korea.
  • Lee DS; Research Center, SillaJen, Inc, Seongnam, Gyeonggi-do, Republic of Korea.
  • Oh K; Research Center, SillaJen, Inc, Seongnam, Gyeonggi-do, Republic of Korea.
J Immunother Cancer ; 11(1)2023 01.
Article em En | MEDLINE | ID: mdl-36717184

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Oncolíticos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Oncolíticos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article